Xinbo Huang
Shenzhen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Screening and characterization of DNA aptamers that modulate prime editing.
Journal: Frontiers in molecular biosciences
Published: January 23, 2025
CRISPR applications in cancer diagnosis and treatment.
Journal: Cellular & molecular biology letters
Published: May 11, 2023
Synthetic Circular gRNA Mediated Biological Function of CRISPR-(d)Cas9 System.
Journal: Frontiers in cell and developmental biology
Published: January 27, 2022
Screening DNA aptamers that control the DNA cleavage, homology-directed repair, and transcriptional regulation of the CRISPR-(d)Cas9 system.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: September 14, 2021
Targeted Demethylation of the PLOD2 mRNA Inhibits the Proliferation and Migration of Renal Cell Carcinoma.
Journal: Frontiers in molecular biosciences
Published: March 03, 2021
A Light-Inducible Split-dCas9 System for Inhibiting the Progression of Bladder Cancer Cells by Activating p53 and E-cadherin.
Journal: Frontiers in molecular biosciences
Published: November 10, 2020
Fifteen-MiRNA-Based Signature Is a Reliable Prognosis-Predicting Tool for Prostate Cancer Patients.
Journal: International journal of medical sciences
Published: June 12, 2020
LncRNA NRON promotes the proliferation, metastasis and EMT process in bladder cancer.
Journal: Journal of Cancer
Published: June 27, 2019
MiR-31-5p acts as a tumor suppressor in renal cell carcinoma by targeting cyclin-dependent kinase 1 (CDK1).
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 27, 2018
N6-methyladenosine demethylase FTO suppresses clear cell renal cell carcinoma through a novel FTO-PGC-1α signalling axis.
Journal: Journal of cellular and molecular medicine
Published: August 28, 2018
Last Updated: 09/26/2026